Literature DB >> 27173185

Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.

N C S Oliveira1, T H B Gomig1, H H Milioli1, F Cordeiro2, G G Costa1, C A Urban3, R S Lima3, I J Cavalli1, E M S F Ribeiro1.   

Abstract

Breast cancer is the second most common cancer worldwide and the first among women. Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) are the two major histological subtypes, and the clinical and molecular differences between them justify the search for new markers to distinguish them. As proteomic analysis allows for a powerful and analytical approach to identify potential biomarkers, we performed a comparative analysis of IDC and ILC samples by using two-dimensional electrophoresis and mass spectrometry. Twenty-three spots were identified corresponding to 10 proteins differentially expressed between the two subtypes. ACTB, ACTG, TPM3, TBA1A, TBA1B, VIME, TPIS, PDIA3, PDIA6, and VTDB were upregulated in ductal carcinoma compared to in lobular carcinoma samples. Overall, these 10 proteins have a key role in oncogenesis. Their specific functions and relevance in cancer initiation and progression are further discussed in this study. The identified peptides represent promising biomarkers for the differentiation of ductal and lobular breast cancer subtypes, and for future interventions based on tailored therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27173185     DOI: 10.4238/gmr.15027701

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

3.  Lipidomics investigations into the tissue phospholipidomic landscape of invasive ductal carcinoma of the breast.

Authors:  Ravindra Taware; Tushar H More; Muralidhararao Bagadi; Khushman Taunk; Anupama Mane; Srikanth Rapole
Journal:  RSC Adv       Date:  2020-12-22       Impact factor: 3.361

4.  Profiling plasma extracellular vesicle by pluronic block-copolymer based enrichment method unveils features associated with breast cancer aggression, metastasis and invasion.

Authors:  Zhenyu Zhong; Matthew Rosenow; Nick Xiao; David Spetzler
Journal:  J Extracell Vesicles       Date:  2018-04-05

5.  Long disease-free survival (48 months) in a breast cancer patient with ovarian and pelvic metastasis-a case report.

Authors:  Yu Feng; Xia Zhao; Shuzhen Lv; Bingjun Xiong; Yanping Li; Man Zhang
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.